drugset / Trial / NCT00006014
SU5416 in Treating Patients With Malignant Mesothelioma
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of SU5416 in treating patients who have malignant mesothelioma. SU5416 may stop the growth of malignant mesothelioma by stopping blood flow to the tumor.
Timeline
- Start
- 2000-08
- Primary completion
- 2007-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | semaxanib | Small molecule | — | Intravenous |